Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-9-29
pubmed:abstractText
Renewal of stem cells differs from cancer cell growth in self-controlled cell division. The mir-302 microRNA (miRNA) family (mir-302s) is expressed most abundantly in slow-growing human embryonic stem (ES) cells, and quickly decreases after cell differentiation and proliferation. Therefore, mir-302s was investigated as one of the key factors essential for maintenance of ES cell renewal and pluripotency in this study. The Pol-II-based intronic miRNA expression system was used to transgenically transfect the mir-302s into several human cancer cell lines. The mir-302-transfected cells, namely, miRNA-induced pluripotent stem (mirPS) cells, not only expressed many key ES cell markers, such as Oct3/4, SSEA-3, SSEA-4 ,Sox2, and Nanog, but also had a highly demethylated genome similar to a reprogrammed zygotic genome. Microarray analyses further revealed that genome-wide gene expression patterns between the mirPS and human ES H1 and H9 cells shared over 86% similarity. Using molecular guidance in vitro, these mirPS cells could differentiate into distinct tissue cell types, such as neuron-, chondrocyte-, fibroblast-, and spermatogonia-like primordial cells. Based on these findings, we conclude that mir-302s not only function to reprogram cancer cells into an ES-like pluripotent state but also to maintain this state under a feeder-free cultural condition, which may offer a great opportunity for therapeutic intervention.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-11689955, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-12769851, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-14550267, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-14744438, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-15183728, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-15364901, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-16450009, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-16810240, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-16904174, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-16957386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-17554336, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-17554338, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-17589500, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-17981704, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-18029452, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-18035408, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-18157115, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-18443585, http://linkedlifedata.com/resource/pubmed/commentcorrection/18755840-9804556
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1469-9001
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2115-24
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.
pubmed:affiliation
Department of Cell and Neurobiology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. lins@usc.edu
pubmed:publicationType
Journal Article